21 results on '"Acosta, Edward P."'
Search Results
2. Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID‐19 Therapeutic Development
3. Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing
4. Sensitivity of ivacaftor to drug-drug interactions with rifampin, a cytochrome P450 3A4 inducer
5. Cerebrospinal fluid concentrations of tenofovir and emtricitabine in the setting of HIV‐1 protease inhibitor‐based regimens
6. Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of age
7. Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations
8. Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose
9. Acceptable Plasma Concentrations of Raltegravir and Etravirine When Administered by Gastrostomy Tube in a Patient with Advanced Multidrug-Resistant Human Immunodeficiency Virus Infection
10. Immune Activation Mediated Change in Alpha-1-Acid Glycoprotein: Impact on Total and Free Lopinavir Plasma Exposure
11. The Effect of Acid Reduction With a Proton Pump Inhibitor on the Pharmacokinetics of Lopinavir or Ritonavir in HIV‐Infected Patients on Lopinavir/Ritonavir‐Based Therapy
12. Hierarchical Bayesian inference for HIV dynamic differential equation models incorporating multiple treatment factors
13. Pharmacokinetics of an Indinavir-Ritonavir-Fosamprenavir Regimen in Patients with Human Immunodeficiency Virus
14. Lopinavir/Ritonavir Pharmacokinetic Profile: Impact of Sex and Other Covariates Following a Change From Twice‐Daily to Once‐Daily Therapy
15. Pharmacokinetics of Saquinavir With Atazanavir or Low-Dose Ritonavir Administered Once Daily (ASPIRE I) or Twice Daily (ASPIRE II) in Seronegative Volunteers
16. Development of a sensitive and specific liquid chromatography/mass spectrometry method for the determination of tenofovir in human plasma
17. Effect of Seville Orange Juice and Grapefruit Juice on Indinavir Pharmacokinetics
18. Indinavir Concentrations and Antiviral Effect
19. Concentration-controlled zidovudine therapy*
20. Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID-19 Therapeutic Development.
21. Cerebrospinal fluid concentrations of tenofovir and emtricitabine in the setting of HIV-1 protease inhibitor-based regimens.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.